Aflac Incorporated (AFL)

Over the past six months, Aflac's stock has been impacted by several key events. Aflac released its Q2 2025 earnings on August 5, 2025. On August 12, 2025, Aflac's Board of Directors authorized the purchase of up to 100 million additional shares of its common stock. The company reported its Q3 2025 earnings on November 4, 2025. Aflac announced its Q4 2025 results on February 4, 2026, reporting strong financial results with adjusted earnings per diluted share of $1.57 and revenue of $4.87 billion. Aflac Japan saw a significant sales increase of 15.7% for the fourth quarter and 16% for the year. Aflac deployed a record $3.5 billion to repurchase 33 million shares and paid $1.2 billion in dividends. Aflac's stock has delivered a 13.10% change over the past year, with a 52-week range between $96.95 and $119.32, and a gain of 14.54% over the past six months.

Explicit data detailing seasonal fluctuations in demand for Aflac's insurance products and services was not found in the provided information. However, the nature of supplemental health and life insurance generally suggests a relatively stable and ongoing demand rather than significant seasonal peaks and troughs. The company has reported consistent premium persistency in both its U.S. and Japan segments, indicating a steady retention of policies. Aflac also focuses on organic insurance policy growth in both markets.

Aflac, Inc. is a Fortune 500 insurance company specializing in supplemental health and life insurance products, operating within the financial services sector. Aflac provides voluntary payroll insurance products designed to cover expenses not typically paid by primary medical insurance. Its major product offerings in the United States include accident, cancer, critical illness, hospital indemnity, dental, vision, and life insurance. In Japan, Aflac Japan offers a range of products such as cancer, medical, nursing care, whole life, GIFT, WAYS, child endowment, and Tsumitasu insurance products. The company serves approximately 50 million people globally.

Aflac's operations are primarily concentrated in the United States and Japan. Japan represents the larger segment, historically contributing approximately 70% of total revenues through cancer and medical insurance products. The U.S. market accounts for roughly 30% of total revenues, primarily through voluntary workplace benefits. Aflac is recognized as the largest provider of guaranteed-renewable insurance in the United States and the largest life insurer in Japan in terms of individual policies in force.

Aflac has maintained a strong brand reputation over the past year. Aflac was recognized as a Fortune Most Admired Company for the 23rd time as of February 6, 2024. In 2025, the company was included in Fortune's World's Most Admired Companies for 24 years and recognized by Ethisphere as one of the World's Most Ethical Companies for 19 consecutive years. The company also celebrated its 70th anniversary and the 25th anniversary of the Aflac Duck.

Aflac Incorporated's stock ownership is a mix of institutional, retail, and individual investors. Institutional investors hold approximately 33.90% of the company's stock, while insiders own about 0.63%, and public companies and individual investors hold 65.47%. Major institutional owners include Vanguard Group Inc., Japan Post Holdings Co., Ltd., BlackRock, Inc., State Street Corp., Wells Fargo & Company/mn, Geode Capital Management, Llc, Morgan Stanley and Northern Trust Corp.